According to a new report Global DNA Diagnostics Market (2016-2022), published by KBV Research, the global DNA Diagnostics Market attained a market size of $11,592 million in 2015 and it is expected to reach $25,851.1 million by 2022, growing at a CAGR of 12.2% during 2016 -2022.
The North America market dominated the Global DNA Diagnostics Market in 2015, and would reach a market size of $9.2 billion by 2022, growing at a CAGR of 11.4% during the forecast period. The Europe market is expected to attain a market size of $8.4 billion by 2022. However, Asia-Pacific market is expected to grow at CAGR of 14.6% during 2016-2022.
The Instruments market contributed the larger revenue share to the Global DNA Diagnostics Market in 2015, and is expected to grow at a CAGR of 12.7% during the forecast period. The Reagents market is expected attain a market size of $3 billion by 2022.
The Clinical confirmation diagnostics market holds the largest revenue share in the Global DNA Diagnostics Market in 2015, and would grow at a CAGR of 11.7% during the forecast period. The Oncology market is expected to attain a market size of $5.0 billion by 2022.
The report highlights the adoption of DNA Diagnostics, globally.Based on the Product Types, the Global DNA Diagnostics Market is segmented into Instruments, Reagents and Service & software segment. Based on the Application, the market is bifurcated into Oncology, Infectious disease testing, Myogenic disorder diagnosis, Clinical confirmation diagnostics, Prenatal diagnosis, Pre-implantation diagnostics andother segments. Based on the Technology, the market is bifurcated into PCR, Microarrays, In situ hybridization, Sequencing Technology, Mass Spectrometry andother segments. Further, the market is segmented into POC (Point-of-Care), Central Laboratories and Self-Testing segments based on the End Users. The geographies included in the report are North America, Europe, Asia Pacific and LAMEA (Latin America, Middle East and Africa).
Key Players profiled in the report includes Sysmex Corporation, Bayer Corporation, Roche Diagnostics, Abbott Laboratories, Cepheid Inc, Hologic Corporation, Illumina, Novartis International Ag, Thermo Fisher Scientific Inc. and Bio-Rad Laboratories.
The market is segmented based on Product Types, Application, Technology, End User and Geography.
Global DNA Diagnostics Market, by Product Type
- Service & software
Global DNA Diagnostics Market, by Application
- Infectious disease testing
- Myogenic disorder diagnosis
- Clinical confirmation diagnostics
- Prenatal diagnosis
- Pre-implantation diagnostics
Global DNA Diagnostics Market, by Technology
- In situ hybridization
- Sequencing Technology
- Mass Spectrometry
Global DNA Diagnostics Market, by End User
- POC (Point-of-Care)
- Central Laboratories
Global DNA Diagnostics Market, by Geography
- North America
- Rest of North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Sysmex Corporation
- Bayer Corporation
- Roche Diagnostics
- Abbott Laboratories
- Cepheid Inc
- Hologic Corporation
- Novartis International Ag
- Thermo Fisher Scientific Inc. and
- Bio-Rad Laboratories
Market Research & Statistics (MRAS) is a Market Research brand owned solely by Marqual IT Solutions Pvt. Ltd., an India based IT company. With years of experience in the research field, we have gained grass root knowledge about the gaps prevailing within the research industry. With innovative products and solutions such as Market Research and Analytics Tool, Sales intelligence reports, R&D intelligence, Industry wide Investment trends, etc. we are growing to be a leading Market Research Company within the landscape of Market Research sector. Each of our innovative products is offered through individualistic brand name and with Market Research & Statistics, we specialize in publisher model.